YSB Inc.
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDocto… Read more
YSB Inc. (B1S) - Total Assets
Latest total assets as of June 2025: €6.78 Billion EUR
Based on the latest financial reports, YSB Inc. (B1S) holds total assets worth €6.78 Billion EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
YSB Inc. - Total Assets Trend (2021–2024)
This chart illustrates how YSB Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
YSB Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
YSB Inc.'s total assets of €6.78 Billion consist of 79.6% current assets and 20.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 15.5% |
| Accounts Receivable | €34.16 Million | 0.5% |
| Inventory | €1.46 Billion | 22.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €526.50 Million | 8.1% |
| Goodwill | €273.29 Million | 4.2% |
Asset Composition Trend (2021–2024)
This chart illustrates how YSB Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: YSB Inc.'s current assets represent 79.6% of total assets in 2024, an increase from 74.9% in 2021.
- Cash Position: Cash and equivalents constituted 15.5% of total assets in 2024, up from 11.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 3.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 22.6% of total assets.
YSB Inc. Competitors by Total Assets
Key competitors of YSB Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
YSB Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - YSB Inc. generates 2.76x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, YSB Inc. generates $ 0.23 in net profit.
YSB Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.24 | 1.47 | 1.47 |
| Quick Ratio | 0.85 | 1.08 | 1.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €1.01 Billion | € 1.53 Billion | € 1.53 Billion |
YSB Inc. - Advanced Valuation Insights
This section examines the relationship between YSB Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.36 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 24.6% |
| Total Assets | €6.50 Billion |
| Market Capitalization | $145.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values YSB Inc.'s assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: YSB Inc.'s assets grew by 24.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for YSB Inc. (2021–2024)
The table below shows the annual total assets of YSB Inc. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €6.50 Billion | +24.62% |
| 2023-12-31 | €5.21 Billion | +26.85% |
| 2022-12-31 | €4.11 Billion | +19.56% |
| 2021-12-31 | €3.44 Billion | -- |